These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19903847)

  • 21. Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide.
    Issaeva N; Friedler A; Bozko P; Wiman KG; Fersht AR; Selivanova G
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13303-7. PubMed ID: 14595027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 stabilization can be uncoupled from its role in transcriptional activation by loss of PTTG1/securin.
    Bernal JA; Hernández A
    J Biochem; 2007 May; 141(5):737-45. PubMed ID: 17383977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
    Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
    Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
    Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
    Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved CPEs in the p53 3' untranslated region influence mRNA stability and protein synthesis.
    Rosenstierne MW; Vinther J; Mittler G; Larsen L; Mann M; Norrild B
    Anticancer Res; 2008; 28(5A):2553-9. PubMed ID: 19035278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monomeric but not trimeric clathrin heavy chain regulates p53-mediated transcription.
    Ohmori K; Endo Y; Yoshida Y; Ohata H; Taya Y; Enari M
    Oncogene; 2008 Apr; 27(15):2215-27. PubMed ID: 17952123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppressor p53 gene forms multiple isoforms: evidence for single locus origin and cytoplasmic complex formation with heat shock proteins.
    Selkirk JK; He C; Patterson RM; Merrick BA
    Electrophoresis; 1996 Nov; 17(11):1764-71. PubMed ID: 8982609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting.
    Liu Y; Asch H; Kulesz-Martin MF
    Cancer Res; 2001 Jul; 61(14):5402-6. PubMed ID: 11454683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of securin promotes colorectal cancer cell death via a p53-independent pathway after radiation.
    Chiu SJ; Hsu TS; Chao JI
    Chem Biol Interact; 2007 Dec; 170(3):153-61. PubMed ID: 17854787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy.
    Resnick-Silverman L; Manfredi JJ
    J Cell Biochem; 2006 Oct; 99(3):679-89. PubMed ID: 16676359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAGED2: a novel p53-dissociator.
    Papageorgio C; Brachmann R; Zeng J; Culverhouse R; Zhang W; McLeod H
    Int J Oncol; 2007 Nov; 31(5):1205-11. PubMed ID: 17912449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and functional characterization of a novel unspliced transcript variant of HIC-1 in human cancer cells exposed to adverse growth conditions.
    Mondal AM; Chinnadurai S; Datta K; Chauhan SS; Sinha S; Chattopadhyay P
    Cancer Res; 2006 Nov; 66(21):10466-77. PubMed ID: 17079468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity.
    Yoshida Y; Izumi H; Torigoe T; Ishiguchi H; Yoshida T; Itoh H; Kohno K
    Oncogene; 2004 May; 23(25):4371-9. PubMed ID: 15064727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.
    Kakudo Y; Shibata H; Otsuka K; Kato S; Ishioka C
    Cancer Res; 2005 Mar; 65(6):2108-14. PubMed ID: 15781620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.
    Hui L; Zheng Y; Yan Y; Bargonetti J; Foster DA
    Oncogene; 2006 Nov; 25(55):7305-10. PubMed ID: 16785993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 and breast cancer, an update.
    Lacroix M; Toillon RA; Leclercq G
    Endocr Relat Cancer; 2006 Jun; 13(2):293-325. PubMed ID: 16728565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.